Lactosylated IR820/DOX Co-Assembled Nanodrug for Synergetic Antitumour Therapy

INTRODUCTION: Synergistic treatment integrating photothermal therapy (PTT) and chemotherapy is a promising strategy for hepatocellular carcinoma (HCC). However, the most commonly used photothermal agent, IR820, and chemotherapeutic drug, doxorubicin hydrochloride (DOX), are both hydrophilic molecule...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yue, Huang, Chunzhi, Luan, Yuxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320228/
https://www.ncbi.nlm.nih.gov/pubmed/32606687
http://dx.doi.org/10.2147/IJN.S247617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320228/
https://www.ncbi.nlm.nih.gov/pubmed/32606687
http://dx.doi.org/10.2147/IJN.S247617

Ejemplares similares